Cambrian BioPharma
Cambrian BioPharma is a startup headquartered in New York, United States, founded in 2019. It has raised at least $23.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Cambrian BioPharma has raised at least $23.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Cambrian BioPharma sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in New York
Related
- Innovation profile of New York
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Cambrian BioPharma do?
Cambrian BioPharma is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Cambrian BioPharma raised?
At least $23.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Cambrian BioPharma based?
Cambrian BioPharma is headquartered in New York, United States.
When was Cambrian BioPharma founded?
Cambrian BioPharma was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.